Aditya Birla Sun Life Pharma and Healthcare Fund vs Mirae Asset Nifty 500 Healthcare ETF
Direct Plan where a fund has one, Growth option · Data as on 30-10-2026
Aditya Birla Sun Life Pharma and Healthcare Fund is a Thematic fund and Mirae Asset Nifty 500 Healthcare ETF is an ETF fund. Aditya Birla Sun Life Pharma and Healthcare Fund charges 1.08% a year and Mirae Asset Nifty 500 Healthcare ETF 0.35%. Their portfolios overlap 57.0%: they hold 26 of the same securities.
Aditya Birla Sun Life Pharma and Healthcare Fund
Thematic
- Expense ratio
- 1.08%
- NAV
- ₹39.28
Mirae Asset Nifty 500 Healthcare ETF
ETF
- Expense ratio
- 0.35%
- NAV
- ₹21.44
Which is better, Aditya Birla Sun Life Pharma and Healthcare or Mirae Asset Nifty 500 Healthcare ETF? Key differences
It depends on what you want from the fund. These are the differences in numbers, from the data on this page.
- Mirae Asset Nifty 500 Healthcare ETF costs less: 0.35% a year against 1.08%.
- Aditya Birla Sun Life Pharma and Healthcare fell less in its worst fall since 11-02-2026: −9.6% against −9.6%.
- Aditya Birla Sun Life Pharma and Healthcare is the larger fund: ₹1,078 Cr against ₹15 Cr.
- Their portfolios overlap 57.0%: 26 of the same holdings.
Past returns do not promise future returns. This page is information, not investment advice.
Key facts
From each fund's scheme summary document and AMFI
| Fact | Aditya Birla Sun Life Pharma and Healthcare Fund | Mirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| Fund house | Aditya Birla Sun Life Mutual Fund | Mirae Asset Mutual Fund |
| Category | Thematic | ETF |
| AUM | ₹1,078 Cr (30-09-2026) | ₹15 Cr (30-09-2026) |
| NAV | ₹39.28 (Direct) | ₹21.44 |
| Expense ratio (Direct) | 1.08% | Not available |
| Expense ratio (Regular) | 2.31% | Not available |
| Riskometer | Very High | Very High |
| Benchmark | BSE Healthcare TRI | Nifty500 Healthcare TRI |
| Launch date | 11-07-2019 | Not available |
| Minimum investment | ₹1,000 | On exchange in multiple of 1 unit. With AMC: In multiples of 5,000 units |
| Lock in | None | None |
| Fund managers | Dhaval Shah | Ekta Gala, amp, Ritesh Patel |
| Exit load | Exit load of 1% if redeemed within 30 days. | NIL |
Aditya Birla Sun Life Pharma and Healthcare vs Mirae Asset Nifty 500 Healthcare ETF: Returns Comparison
Returns as on 30-10-2026. Up to one year they are absolute returns. Longer periods are a rate per year.
| Fund | 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y |
|---|---|---|---|---|---|---|---|
| Aditya Birla Sun Life Pharma and Healthcare Fund (Direct) | −1.11% | −2.63% | +12.00% | +14.15% | +21.08% | +14.76% | -- |
| Mirae Asset Nifty 500 Healthcare ETF | +1.43% | −0.66% | +12.95% | -- | -- | -- | -- |
| Thematic average | −2.09% | −4.52% | +0.86% | −1.22% | +13.76% | +11.62% | -- |
Category average: the average of the 235 Thematic funds, same plan type.
Aditya Birla Sun Life Pharma and Healthcare vs Mirae Asset Nifty 500 Healthcare ETF: Year-wise Returns
| Year | Aditya Birla Sun Life Pharma and HealthcareAditya Birla Sun Life Pharma and Healthcare | Mirae Asset Nifty 500 Healthcare ETFMirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| 2026to date | +15.94% | -- |
| 2025 | −3.09% | -- |
| 2024 | +37.69% | -- |
| 2023 | +39.58% | -- |
| 2022 | −11.31% | -- |
| 2021 | +21.36% | -- |
Aditya Birla Sun Life Pharma and Healthcare vs Mirae Asset Nifty 500 Healthcare ETF: Rolling Returns
Every holding period of both funds, against BSE Healthcare TRI, the benchmark of Aditya Birla Sun Life Pharma and Healthcare Fund
Aditya Birla Sun Life Pharma and Healthcare vs Mirae Asset Nifty 500 Healthcare ETF: Risk and Drawdowns
How much each fund swings, and the worst fall over the same days
Risk and return
| Measure | Aditya Birla Sun Life Pharma and Healthcare Fund (Direct) | Mirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| Return (CAGR) | +20.52% | +23.46% |
| Standard deviation | 14.89% | 14.16% |
| Sharpe ratio | 1.03 | 1.29 |
| Sortino ratio | 1.51 | 1.90 |
| Maximum drawdown | −20.5% (17-06-2022) | −9.6% (23-10-2026) |
| Beta | 0.88 | 1.00 |
| Alpha | +1.23% | −0.22% |
From daily NAVs, 11-07-2019 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
Drawdowns
How far below its previous high each one was on every day: the falls an investor had to sit through. 0% means it was at a new high.
Aditya Birla Sun Life Pharma and Healthcare Fund (Direct)
Mirae Asset Nifty 500 Healthcare ETF
BSE Healthcare TRI
| Fund | Worst fall | High before it | Bottom | Back at the high | Time to climb back | Below its high today |
|---|---|---|---|---|---|---|
| Aditya Birla Sun Life Pharma and Healthcare Fund (Direct) | −9.6% | 31-08-2026 | 23-10-2026 | Not yet | -- | −4.7% |
| Mirae Asset Nifty 500 Healthcare ETF | −9.6% | 23-09-2026 | 23-10-2026 | Not yet | -- | −3.0% |
| BSE Healthcare TRI | −9.9% | 23-09-2026 | 23-10-2026 | Not yet | -- | −3.8% |
From daily values since 11-02-2026, the first day every fund has.
Aditya Birla Sun Life Pharma and Healthcare vs Mirae Asset Nifty 500 Healthcare ETF: Portfolio Overlap
From each fund's latest monthly portfolio: Aditya Birla Sun Life Pharma and Healthcare Fund, September 2026; Mirae Asset Nifty 500 Healthcare ETF, September 2026
Holdings in common
- Overlap
- 57.0%
- Held by both
- 26
- Only in Aditya Birla Sun Life Pharma and Healthcare
- 13
- Only in Mirae Asset Nifty 500 Healthcare ETF
- 18
| Security | % of Aditya Birla Sun Life Pharma and Healthcare | % of Mirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 8.61% | 10.13% |
| Apollo Hospitals Enterprise Ltd. | 6.44% | 6.24% |
| Cipla Ltd. | 6.38% | 5.62% |
| Torrent Pharmaceuticals Ltd. | 9.28% | 5.24% |
| Aurobindo Pharma Ltd. | 4.52% | 3.43% |
| Lupin Ltd. | 2.94% | 3.66% |
| Fortis Healthcare Ltd. | 2.42% | 2.98% |
| Divi's Laboratories Ltd. | 2.24% | 8.76% |
| Mankind Pharma Ltd. | 3.62% | 2.10% |
| IPCA Laboratories Ltd. | 2.71% | 1.98% |
| Gland Pharma Ltd. | 2.70% | 1.71% |
| Alkem Laboratories Ltd. | 1.68% | 2.31% |
| Sai Life Sciences Ltd. | 4.49% | 1.56% |
| Biocon Ltd. | 1.45% | 1.91% |
| Ajanta Pharma Ltd. | 4.35% | 1.22% |
| Dr. Lal Path labs Ltd. | 3.51% | 1.15% |
| Dr. Reddy's Laboratories Ltd. | 1.13% | 5.58% |
| Abbott India Ltd. | 3.26% | 1.04% |
| Piramal Pharma Ltd. | 1.22% | 0.95% |
| Glaxosmithkline Pharmaceuticals Ltd. | 0.83% | 0.85% |
| Anthem Biosciences Ltd. | 1.13% | 0.69% |
| Max Healthcare Institute Ltd. | 0.60% | 5.13% |
| Emcure Pharmaceuticals Ltd. | 3.21% | 0.60% |
| Natco Pharma Ltd. | 0.92% | 0.55% |
| Vijaya Diagnostic Centre Ltd. | 1.04% | 0.52% |
| Syngene International Ltd. | 0.64% | 0.51% |
Overlap: for each holding both funds own, the smaller of its two weights, added up. 57.0% means 57.0% of each fund's money sits in positions the other also holds. Matched by ISIN. Cash and hedged positions are left out.
Largest holdings only in Aditya Birla Sun Life Pharma and Healthcare Fund
| Security | % of fund |
|---|---|
| Corona Remedies Ltd. | 2.27% |
| Procter & Gamble Health Ltd. | 1.82% |
| Thyrocare Technologies Ltd. | 1.76% |
| Jupiter Life Line Hospitals Ltd. | 1.55% |
| Metropolis Healthcare Ltd. | 1.48% |
Largest holdings only in Mirae Asset Nifty 500 Healthcare ETF
| Security | % of fund |
|---|---|
| Laurus Labs Ltd. | 5.72% |
| Glenmark Pharmaceuticals Ltd. | 2.61% |
| Zydus Lifesciences Ltd. | 2.14% |
| Krishna Institute of Medical Sciences Ltd. | 1.48% |
| Aster DM Quality Care Ltd. | 1.38% |
Asset and sector split
Share of each fund, from its latest monthly portfolio
Asset allocation
| Asset | Aditya Birla Sun Life Pharma and Healthcare | Mirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| Equity | 97.9% | 100.0% |
| Debt | 0.0% | 0.0% |
| Cash and others | 2.1% | 0.0% |
Market cap of stocks
| Market cap | Aditya Birla Sun Life Pharma and Healthcare | Mirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| Large Cap | 32.9% | 36.0% |
| Mid Cap | 30.6% | 45.6% |
| Small Cap | 31.7% | 18.3% |
| Not on AMFI's list | 2.6% | 0.0% |
Share of the whole fund. Groups follow AMFI's latest list: Large Cap is the 100 largest companies, Mid Cap the next 150, Small Cap the rest.
Largest sectors
| Sector | Aditya Birla Sun Life Pharma and Healthcare | Mirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| Pharmaceuticals & Biotechnology | 74.9% | 77.8% |
| Healthcare Services | 21.6% | 21.7% |
| Insurance | 0.7% | 0.0% |
| Chemicals & Petrochemicals | 0.7% | 0.0% |
| Healthcare Equipment & Supplies | 0.0% | 0.5% |
The six largest sectors of each fund's stocks, % of the fund.
Aditya Birla Sun Life Pharma and Healthcare vs Mirae Asset Nifty 500 Healthcare ETF: Expense Ratio
What each plan charges a year, from AMFI's expense ratio file
| Charge | Aditya Birla Sun Life Pharma and Healthcare Fund | Mirae Asset Nifty 500 Healthcare ETF |
|---|---|---|
| Total expense ratio (Direct) | 1.08% | Not available |
| Base expense ratio (Direct) | 0.84% | 0.00% |
| Total expense ratio (Regular) | 2.31% | Not available |
| Base expense ratio (Regular) | 1.91% | 0.16% |
The expense ratio comes out of the fund's assets every day, so every return on this page is already after it. Base expense ratio: the fund house's own fee. The total adds brokerage, transaction costs, and levies with GST.
More comparisons
Each fund against the others of its category
Compare Aditya Birla Sun Life Pharma and Healthcare with
- Aditya Birla Sun Life Pharma and Healthcare vs Nippon India Taiwan Equity
- Aditya Birla Sun Life Pharma and Healthcare vs HDFC Defence
- Aditya Birla Sun Life Pharma and Healthcare vs HDFC Pharma and Healthcare
- Aditya Birla Sun Life Pharma and Healthcare vs SBI Healthcare Opportunities
- Aditya Birla Sun Life Pharma and Healthcare vs Aditya Birla Sun Life International Equity
Aditya Birla Sun Life Pharma and Healthcare Fund vs Mirae Asset Nifty 500 Healthcare ETF: Frequently Asked Questions
What is the difference between Aditya Birla Sun Life Pharma and Healthcare Fund and Mirae Asset Nifty 500 Healthcare ETF?
Aditya Birla Sun Life Pharma and Healthcare Fund is a Thematic fund, Mirae Asset Nifty 500 Healthcare ETF is an ETF fund, run by Aditya Birla Sun Life Mutual Fund and Mirae Asset Mutual Fund. Their portfolios overlap 57.0%. Aditya Birla Sun Life Pharma and Healthcare Fund charges 1.08% a year and Mirae Asset Nifty 500 Healthcare ETF 0.35%.
Which has the lower expense ratio, Aditya Birla Sun Life Pharma and Healthcare Fund or Mirae Asset Nifty 500 Healthcare ETF?
Mirae Asset Nifty 500 Healthcare ETF charges less: 0.35% a year against 1.08%. These are the total expense ratios reported to AMFI.
How much do Aditya Birla Sun Life Pharma and Healthcare Fund and Mirae Asset Nifty 500 Healthcare ETF overlap?
57.0%. They hold 26 of the same securities, the largest shared ones being SUNPHARMA, APOLLOHOSP, CIPLA. From each fund's latest monthly portfolio.
Which is riskier, Aditya Birla Sun Life Pharma and Healthcare Fund or Mirae Asset Nifty 500 Healthcare ETF?
On SEBI's riskometer, Aditya Birla Sun Life Pharma and Healthcare Fund is rated Very High and Mirae Asset Nifty 500 Healthcare ETF Very High. Over their common history, the standard deviation of daily returns was 14.89% and 14.16% a year.
Can I invest in both Aditya Birla Sun Life Pharma and Healthcare Fund and Mirae Asset Nifty 500 Healthcare ETF?
Yes. 57.0% of each fund's money sits in the same holdings, so a large part of the two investments would move together.
Who manages Aditya Birla Sun Life Pharma and Healthcare Fund and Mirae Asset Nifty 500 Healthcare ETF?
Aditya Birla Sun Life Pharma and Healthcare Fund: Dhaval Shah. Mirae Asset Nifty 500 Healthcare ETF: Ekta Gala, amp, Ritesh Patel.
Sources: NAV and expense ratio from AMFI. Holdings from each fund house's monthly portfolio statement. Fund facts from each scheme summary document.
This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.